Cargando…
Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (a novel coronavirus), which was first identified amid an outbreak of respiratory illness cases in Wuhan, China and declared a global health emergency, is currently considered an ad...
Autores principales: | Valencia, Guillermo Arturo, Neciosup, Silvia, Gómez, Henry L, Benites, Maria Del Pilar, Falcón, Silvia, Moron, David, Veliz, Karin, Maldonado, Mike, Auqui, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829627/ https://www.ncbi.nlm.nih.gov/pubmed/33552937 http://dx.doi.org/10.5306/wjco.v12.i1.31 |
Ejemplares similares
-
Comorbidities and severity of coronavirus disease 2019 patients
por: Radwan, Nashwa M., et al.
Publicado: (2020) -
Immunotherapy in triple-negative breast cancer: A literature review and new advances
por: Valencia, Guillermo Arturo, et al.
Publicado: (2022) -
Stroke in Coronavirus Disease 2019: A Systematic Review
por: Bhatia, Rohit, et al.
Publicado: (2020) -
Review of investigational drugs for coronavirus disease 2019
por: Sharma, Dhruva, et al.
Publicado: (2021) -
The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems
por: Valencia-Mesías, Guillermo, et al.
Publicado: (2021)